An important objective of research in environmental epidemiology is to detect those individuals who, because of their genetic susceptibility to environmental factors, are prone to develop illness. Identifying genetic susceptibility may permit us to determine how environmental factors interact to produce disease and so lead to the development of preventive measures.
Genetic-environmental interactions have been recognized since the early days of genetics. But not until the recent development of biochemical genetics and pharmacogenetics has the potential influence of differential genetic susceptibility in host response to varying environments been appreciated. The studies indicate that genetically determined differences in an individual's constitution may determine how that person will respond to environmental chemical agents (1) .
More recently, it has been found that, in addition to ionizing radiations, many chemical agents can damage DNA, alter its biochemical and physiologic expression and, in some individuals, lead to ill health and disease (2) . The problem is compounded December 1981 because most known environmental agent factors implicated in the major noninfectious diseases are weak; the diseases allegedly caused by them involve low dose rates as well as the interaction of multiple factors.
An early example of genetic-environmental interaction related to disease is differential susceptibility to malaria of children who have or do not have the sickle trait (3) . Other examples include G6PD deficiency-an X-linked trait-and susceptibility to primaquin, and, as found later, differing susceptibility to a host of chemical substances (4) . The abnormal response of erythrocytes in G6PD deficiency to numerous drugs stimulated the development of the field of pharmacogenetics (5) . A variety of genetic systems have been identified through the use of and reaction to medications. A recent example, and a model for studies in the metabolism of carcinogens, revealed genetic differences among individuals in metabolizing the antituberculosis drug isoniazid by liver acetyltransferase. Subsequent studies indicated considerable genetic-racial variation in the inactivation of the drug.
Through the pioneering work of the Millers and many subsequent workers, it is now evident that most procarcinogens are metabolically activated by cellular enzymes to the ultimate chemical carcinogenic form (6) . The process involves the microsomal cytochrome P448-450 enzyme systems which detoxify and metabolize many toxic substances before their elimination. The liver is the major site of these enzymes, but all tissues, including the breast, show some enzymatic activity. Experiments in mice indicate that the metabolism of polycyclic hydrocarbons is under genetic control and that different mouse strains have differing metabolism and susceptibility to carcinogenesis for these substances (7). Kellerman, Shaw and others (8, 9) reported that exposure of human lymphocyte cultures to benzpyrene led to the induction of BP-hydroxylase enzyme and that lymphocytes from lung cancer patients could be induced to higher enzyme levels than lymphocytes from controls. It was suggested that the mechanism might underlie the differential susceptibility to lung cancer in response to cigarette smoke, known to contain benzpyrene and related polycyclic hydrocarbons. The earlier belief that inducibility of BP-hydroxylase was inherited as a simple Mendelian trait giving three distinct genotypes was not confirmed by other researchers. Instead, it appears that there is continuous variation from low to high levels of BP-hydroxylase inducibility among members of the population, indicating a more complex genetic variation in BP-hydroxylase inducibility.
In response to the DNA-damaging action of environmental chemical agents, nature has evolved enzyme systems for DNA repair. The repair mechanisms came to light after Cleaver reported that skin cells from xeroderma pigmentosum, a genetically dominant disease leading to skin cancer, were unable to repair their DNA after damage by ultraviolet light, x-rays and carcinogenic chemicals (10) . Similar defective DNA-repair systems were demonstrated in other rare genetic conditions such as ataxia telangiectasia and in Fanconi's anemia (11) . However, in ordinary cancers, the genetic predisposition probably resides in the differing metabolic rates and the activation of mutagens to carcinogens that tend to overwhelm the normal DNA-repair mechanisms.
Recent work in our laboratory, which deals with the genetic epidemiology of breast cancer, indicates possible genetic-environmental interaction. That breast cancer in some women had a familial component has been known for many years (12) . Women with a first degree relative (mother, sister', daughter) with breast cancer have a two-to threefold increased risk of also developing breast cancer. The risk is increased significantly if the cancer in the relative occurred premenopausally and was bilateral. Very recently, King, Elston, 98 Go, Lynch and Petrakis (13) reported evidence for the existence of an allele that increases susceptibility to human breast cancer in certain very high risk families. The susceptibility allele appears to be linked to the polymorphic glutamate-pyruvate transaminase (GPT) locus on chromosome 10 . However, because the GPT genetic marker is not associated with risk of breast cancer in the general population, it cannot be used as a screening device for susceptibility to breast cancer. Nevertheless, the finding strengthens the likelihood that genetic susceptibility to breast cancer exists and that it might be detected by other techniques. This would enable the investigation of genetic interaction with "environmental" factors. The present study presents some new evidence from our research on nipple aspirates of breast fluid which may be indicative of potential genetic-environmental interactions involving breast epithelium.
Over the past seven years our staff has been investigating the genetic epidemiology and pathophysiology of breast cancer and benign breast disease, with emphasis on breast secretory activity. We have developed a working hypothesis that emphasizes breast epithelial metabolic and secretory activity as a key factor in the pathogenesis of breast disease (14) . The breast epithelium contains the enzymatic mechanism for metabolizing potentially toxic and carcinogenic substances transported in the blood. These genetically conditioned metabolic and physiologic activities may, in the appropriate environmental circumstances, lead to epithelial damage and ultimately to breast disease. Before discussing our most recent cytologic results, some of our basic findings on nipple aspirates of breast fluids will be presented.
The women in this study had voluntarily come to be examined at the University of California Hopsitals and Clinics, the Breast Screening Center of Northern California, and other community health and screening centers. All women completed a questionnaire on their demographic, clinical, marital, reproductive and other characteristics. A specially trained nurse or a physician examined their breasts. On both breasts, nipple aspiration was attempted, employing the technique described previously (15) . A woman was defined as "secretor" if a drop or more of fluid appeared at the nipple surface after application of the breast pump with the syringe retracted to 10 cc and held up to 15 sec. It is necessary to exert this degree of negative pressure to force breast fluid through the closed nipple ducts of most nonlactating adult women In general, our studies of the occurrence of secretion by nipple aspiration appear to be in agreement with selected breast cancer risk factors, reflecting the degree of ovarian activity and its changes in response to reproductive history. These findings are not unexpected, as most known breast cancer risk factors are strongly associated with endocrine and reproductive characteristics.
Biochemical Aspects of Breast Fluid Secretion
Based on our studies, we have proposed that the endocrine and genetically dependent secretory activity of the breast can provide a physiologic mechanism whereby initiating and promoting chemical carcinogens can reach the breast alveolarductal system. In support of this hypothesis, we have found that a variety of exogenously derived substances are secreted by the nonlactating breast (14) . We hypothesize that in genetically predisposed and metabolically activated breast epithelium the uptake and secretion of mutagenic substances conceivably could lead to the initiation, December 1981 accumulation and promotion of mutant epithelial cells and eventually to the emergence of cancer cells or to benign-type breast conditions.
We have found evidence that putative mutagenic substances do reach the breast fluid (16 Based on these findings, we decided to examine the relationship of atypical epithelial hyperplasia and the various risk factors for breast cancer in terms of potential genetic-environmental interactions.
The model depicted in Figure 1 shows the phenotype (atypical epithelial hyperplasia) resulting from a combination of genetic susceptibility (a first-degree family history of breast cancer) and environmental factors (the other breast cancer risk factors-primarily related to the endocrine and reproductive systems) and their interaction. In this model based upon the classic "phenotype = genetics + environment," a first-degree family history of breast cancer is considered as the "genetic susceptibility factor" which may interact with a variety of "environmental" factors. The breast cancer risk factors shown in Figure 1 are considered predominantly environmentally conditioned. Studies by others (22) (23) (24) have attempted to examine the effect of multiple risk factors on breast cancer risk, but have not employed the geneticenvironmental interaction concept presented here.
Women with a first-degree family history of breast cancer are likely to have an increased risk of developing breast cancer and are more prone if they are in the premenopausal age group. As a group, such women would be more likely to possess a gene or genes which might increase the susceptibility and responsiveness of their breast epithelium to "environmental factors." Genes could influence susceptibility to atypical hyperplasia and to breast cancer through their regulation of hormonal stimuli, or by controlling the response of breast epithelial cells to these stimuli and by influencing the metabolism of extrinsic chemical substances. We believe that these types of effects might be detectable as atypical epithelial hyperplasia in breast fluid.
The proportion of atypical cells and the relative tion," where the "genetic" susceptibility factors in (14) .
Women with both a positive first-degree family history of breast cancer and fibrocystic disease were found to have a significantly greater relative risk of atypical hyperplasia than women with only one of these factors. The presence of both factors was associated with an even higher relative risk of cytologic atypical hyperplasia in parous women, in women whose age at first pregnancy was under 20 years and in women using menopausal estrogens.
It must be emphasized that these data are from work still in progress. As noted earlier, the breast epithelia may be exposed through the breast secretory mechanism to exogenously derived chemicals, including mutagenic and carcinogenic substances. These substances might exert greater effects on "genetically susceptible" epithelia of women with both a first degree family history of breast cancer and fibrocystic disease. We suggest that our findings on breast cytology represent an example of genetic and environmental "interac- women with a first degree family history of breast cancer may interact with "environmental factors" which potentially may lead to breast disease. The findings lead us to propose that the breast epitheHum of women who have both positive first-degree family history of breast cancer and clinical fibrocystic disease may be more prone to abnormal differentiation than the breast epithelium of women without these risk factors. The biochemical mechanisms that might underlie these processes are as yet unknown. The use of first-degree family history of breast cancer as "genetic" susceptibility is clearly not completely warranted. Probably the less specific term "host" might have been more correct. However, the positive and consistent findings in combinations of risk factors with FH + compared with FH-women suggests that our approach may be a productive way to attempt to more precisely focus on possible genetic susceptibility factors in breast cancer epidemiology.
Future studies, stratified according to family history of breast cancer and risk factors as presented here, would offer an opportunity for epidemiological and laboratory investigations of potential genetic-environmental interactions of environmental carcinogens, dietary and other factors on the production and reversal of atypical hyperplasia of breast epithelium. Control of atypical hyperplasia might lead to means of preventing breast disease and breast cancer.
